BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10861951)

  • 1. Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2.
    Josephy PD; Bibeau KL; Evans DH
    Environ Mol Mutagen; 2000; 35(4):328-35. PubMed ID: 10861951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
    Kim D; Guengerich FP
    Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
    Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
    Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
    Josephy PD; Batty SM; Boverhof DR
    Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of four allelic variants of human cytochrome P450 1A2.
    Zhou H; Josephy PD; Kim D; Guengerich FP
    Arch Biochem Biophys; 2004 Feb; 422(1):23-30. PubMed ID: 14725854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Kang IH; Kim HJ; Oh H; Park YI; Dong MS
    Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid-mediated expression of the UmuDC mutagenesis proteins in an Escherichia coli strain engineered for human cytochrome P450 1A2-catalyzed activation of aromatic amines.
    Josephy PD; Evans DH; Williamson V; Henry T; Guengerich FP
    Mutat Res; 1999 Oct; 429(2):199-208. PubMed ID: 10526205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
    Parikh A; Josephy PD; Guengerich FP
    Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
    Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
    Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
    Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
    Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
    Josephy PD; Evans DH; Parikh A; Guengerich FP
    Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
    Anari MR; Josephy PD; Henry T; O'Brien PJ
    Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of recombinant human cytochrome P450 1A2 in Escherichia coli bacterial mutagenicity tester strain.
    Chun YJ
    Arch Pharm Res; 1998 Jun; 21(3):305-9. PubMed ID: 9875448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
    Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
    Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase.
    Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y
    Mutat Res; 1999 Jun; 442(2):113-20. PubMed ID: 10393280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
    Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
    Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype.
    Guengerich FP; Parikh A; Turesky RJ; Josephy PD
    Mutat Res; 1999 Jul; 428(1-2):115-24. PubMed ID: 10517985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.
    Liu J; Ericksen SS; Sivaneri M; Besspiata D; Fisher CW; Szklarz GD
    Arch Biochem Biophys; 2004 Apr; 424(1):33-43. PubMed ID: 15019834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Amino-3,4-dimethylimidazo[4,5-f]quinoline induces and inhibits cytochrome P450 from the IA subfamily in chick and rat hepatocytes.
    Sinclair JF; Schaeffer BK; Wood SG; Lambrecht LK; Gorman N; Bement WJ; Smith EL; Sinclair PR; Waldren CA
    Cancer Res; 1992 Jul; 52(13):3615-21. PubMed ID: 1617633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.